Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.280
-0.090 (-6.57%)
Jun 15, 2026, 4:00 PM EDT - Market closed
Pulmonx Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 61.83 | 70.01 | 71.16 | 83.78 | 101.97 | 148.71 |
Short-Term Investments | - | - | 30.58 | 33.56 | 39.4 | 31.56 |
Cash & Short-Term Investments | 61.83 | 70.01 | 101.74 | 117.34 | 141.37 | 180.27 |
Cash Growth | -30.50% | -31.19% | -13.30% | -17.00% | -21.58% | -22.23% |
Accounts Receivable | 10.83 | 12.07 | 13.12 | 12.11 | 8.68 | 6.56 |
Inventory | 20.13 | 19.45 | 18.6 | 19.32 | 19.85 | 16.29 |
Other Current Assets | 3.78 | 3.76 | 4.47 | 4.24 | 4.34 | 4.88 |
Total Current Assets | 92.75 | 101.68 | 136.25 | 150.42 | 168.95 | 208 |
Net Property, Plant & Equipment | 19.71 | 20.25 | 21.45 | 7.43 | 10.5 | 12.89 |
Other Intangible Assets | - | - | - | 0.03 | 0.15 | 0.28 |
Goodwill | 2.33 | 2.33 | 2.33 | 2.33 | 2.33 | 2.33 |
Long-Term Investments | - | - | - | 14.39 | 5.92 | 10.94 |
Other Long-Term Assets | 1.35 | 1.42 | 1.14 | 0.59 | 0.53 | 0.73 |
Total Assets | 119.97 | 129.29 | 162.85 | 177.78 | 193.68 | 235.17 |
Accounts Payable | 3.47 | 3.91 | 3.83 | 1.5 | 1.76 | 1.58 |
Accrued Expenses | 13.73 | 14.56 | 16.47 | 16.23 | 13.28 | 13.37 |
Short-Term Debt | 0.1 | 0.11 | 3.18 | 2.16 | 0.09 | 0.09 |
Current Portion of Leases | 1.24 | 1.21 | 0.78 | 3.07 | 3.23 | 2.2 |
Unearned Revenue | 0.03 | 0.02 | 0.14 | 0.1 | 0.12 | 0.16 |
Other Current Liabilities | 0.33 | 0.26 | 0.05 | 0.09 | 0.02 | 0.15 |
Total Current Liabilities | 18.91 | 20.06 | 24.44 | 23.16 | 18.49 | 17.55 |
Long-Term Debt | 37.21 | 36.99 | 34 | 35.09 | 17.23 | 17.32 |
Long-Term Leases | 17.74 | 18.06 | 18.52 | 1.11 | 3.85 | 6.84 |
Other Long-Term Liabilities | 0.35 | 0.07 | 0.09 | 0.11 | 0.09 | 0.22 |
Total Long-Term Liabilities | 55.3 | 55.12 | 52.6 | 36.31 | 21.18 | 24.38 |
Total Liabilities | 74.21 | 75.18 | 77.04 | 59.47 | 39.67 | 41.93 |
Common Stock | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
Additional Paid-in Capital | 578.76 | 573.27 | 551.21 | 526.8 | 502.71 | 482.89 |
Accumulated Other Comprehensive Income | 2.17 | 2.36 | 2.11 | 2.64 | 1.58 | 1.71 |
Retained Earnings | -535.21 | -521.56 | -467.56 | -411.16 | -350.32 | -291.4 |
Shareholders' Equity | 45.76 | 54.12 | 85.81 | 118.32 | 154.01 | 193.24 |
Total Liabilities & Equity | 119.97 | 129.29 | 162.85 | 177.78 | 193.68 | 235.17 |
Total Debt | 56.29 | 56.36 | 56.47 | 41.42 | 24.4 | 26.46 |
Net Cash (Debt) | 5.54 | 13.65 | 45.27 | 75.92 | 116.97 | 153.81 |
Net Cash Growth | -59.43% | -69.86% | -40.37% | -35.10% | -23.96% | -30.52% |
Net Cash Per Share | 0.13 | 0.34 | 1.16 | 2.00 | 3.15 | 4.26 |
Book Value | 45.76 | 54.12 | 85.81 | 118.32 | 154.01 | 193.24 |
Book Value Per Share | 1.11 | 1.33 | 2.19 | 3.12 | 4.15 | 5.35 |
Tangible Book Value | 43.43 | 51.78 | 83.48 | 115.95 | 151.52 | 190.63 |
Tangible Book Value Per Share | 1.05 | 1.27 | 2.13 | 3.05 | 4.08 | 5.28 |